Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
EV-to-OCF is calculated as enterprise value divided by its cash flow from operations. As of today, ASEP Medical Holdings's Enterprise Value is $3.26 Mil.
ASEP Medical Holdings's Cash Flow from Operations for the trailing twelve months (TTM) ended in Jun. 2026 was $-0.89 Mil. Therefore, ASEP Medical Holdings's EV-to-OCF for today is -3.68.
The historical rank and industry rank for ASEP Medical Holdings's EV-to-OCF or its related term are showing as below:
SEPSF'
s EV-to-OCF Range Over the Past 10 Years
Min: -37.76 Med: -10.61 Max: -2.32
Current: -3.65
During the past 5 years, the highest EV-to-OCF of ASEP Medical Holdings was -2.32. The lowest was -37.76. And the median was -10.61.
SEPSF's EV-to-OCF is ranked better than 53.49% of 1406
companies
in the Biotechnology industry
Industry Median: -3.7
vs SEPSF: -3.65
EV-to-OCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
ASEP Medical Holdings (OTCPK:SEPSF) EV-to-OCF Explanation
EV-to-OCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
ASEP Medical Holdings's PE Ratio (TTM) for today is calculated as:
ASEP Medical Holdings's share price for today is $0.0109.
ASEP Medical Holdings's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.261.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Cash Flow from Operations is an important financial metric because it represents the cash generated from operating activities at a company's disposal. Companies with a low EV-to-OCF ratio, combined with a strong balance sheet are generally considered as undervalued.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Biotechnology subindustry, ASEP Medical Holdings's EV-to-OCF, along with its competitors' market caps and EV-to-OCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
ASEP Medical Holdings EV-to-OCF vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, ASEP Medical Holdings's EV-to-OCF distribution charts can be found below:
* The bar in red indicates where ASEP Medical Holdings's EV-to-OCF falls into.
ASEP Medical Holdings's current Enterprise Value is $3.26 Mil.
ASEP Medical Holdings's Cash Flow from Operations for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.89 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
ASEP Medical Holdings (SEPSF) has a EV-to-OCF of -3.68 as of Sep. 08, 2026. According to the industry distribution chart, ASEP Medical Holdings ranks #654 out of 1406 companies in the Biotechnology industry, placing it in the top 46.5%.
Is ASEP Medical Holdings' EV-to-OCF too high?
ASEP Medical Holdings' current EV-to-OCF is -3.68. Based on the distribution chart, ASEP Medical Holdings ranks #654 out of 1406 companies in the Biotechnology industry, which is above the industry midpoint. Overall, ASEP Medical Holdings has a GF Score™ of 16/100, reflecting its overall financial health beyond just this single metric.
How does ASEP Medical Holdings' EV-to-OCF compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, ASEP Medical Holdings ranks #654 out of 1406 companies for EV-to-OCF. This puts ASEP Medical Holdings in the upper half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-OCF for a Biotechnology company?
A good EV-to-OCF depends on the Biotechnology industry context. However, EV-to-OCF should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-OCF mean?
A high EV-to-OCF can signal that a stock is expensive relative to its fundamentals. ASEP Medical Holdings's current EV-to-OCF is -3.68. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is ASEP Medical Holdings stock overvalued right now?
ASEP Medical Holdings (SEPSF) has a current EV-to-OCF of -3.68. The stock's GF Value™ is $0.03, compared to a current price of $0.01 — trading 63.7% below its estimated fair value. The current EV-to-OCF is -3.68. ASEP Medical Holdings' overall GF Score™ is 16/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-OCF calculated?
EV-to-OCF is calculated from a company's financial statements. For ASEP Medical Holdings (SEPSF), the current EV-to-OCF is -3.68 as of Sep. 08, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is ASEP Medical Holdings (SEPSF) Overvalued in 2026?
Based on GuruFocus' analysis, ASEP Medical Holdings stock appears to be undervalued.
The current stock price of $0.01 is trading 63.7% below its estimated GF Value™ of $0.03.
Key valuation signals for SEPSF:
EV-to-OCF: -3.68
GF Value™: $0.03 vs. price of $0.01 (63.7% below fair value)
No single metric tells the full story. See the SEPSF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
ASEP Medical Holdings Inc is in the business of acquiring research and development assets, technologies and/or businesses in the area of life sciences and medical diagnostics. Diagnostic and therapeutic solutions represent tremendous clinical and commercial potential, through rapid diagnostics and uniquely effective treatments. Its Diagnostic has developed a novel diagnostic assay for the early and rapid risk assessment of sepsis. Therapeutic offering: Patented peptide technology targets infection-causing biofilms and reduces inflammation.
16GF Score
Get the complete analysis for SEPSF
EV-to-OCF is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SEPSF has been successfully added to your 
